Page 32 - Test PDF v5

« Back to Contents ENDOMETRIAL CANCER

LiFE re

Literature for ENYGO

Uterine sarcoma (treatment and follow-up)

Relevant articles retrieved Nov 2015 - Feb 2016 Authors Journal Link to abstract
Kho et al. Obstet Gynecol.
No Title http://www.ncbi.nlm.nih.gov/
1 Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Picerno et al. Int J Gynecol Cancer. pubmed/26855091

Benign Indications. Obstet Gynecol. http://www.ncbi.nlm.nih.gov/
2 Morcellation and the incidence of Occult uterine malignancy. pubmed/26332395
J Minim Invasive Gynecol.
3 Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Raine-Bennett et al. http://www.ncbi.nlm.nih.gov/
Associated With Morcellation. Eur J Obstet Gynecol Reprod pubmed/26646120
Biol.
4 Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: Paul et al. PLoS ONE. http://www.ncbi.nlm.nih.gov/
10 Years' Experience. pubmed/26677821
Am J Obstet Gynecol.
5 Incidence of occult leiomyosarcoma in presumed morcellation cases: a Rodriguez et al. http://www.ncbi.nlm.nih.gov/
database study. J Minim Invasive Gynecol. pubmed/26699101

6 A Retrospective Analysis of the Impact of Myomectomy on Survival in Gao et al. J Minim Invasive Gynecol. http://www.ncbi.nlm.nih.gov/
Uterine Sarcoma. pubmed/26828206

7 Practice patterns and postoperative complications before and after US Food Harris et al. http://www.ncbi.nlm.nih.gov/
and Drug Administration safety communication on power morcellation. pubmed/26314519

8 Impact of the Food and Drug Administration Safety Communication on the Mandato et al. http://www.ncbi.nlm.nih.gov/
Use of Power Morcellator in Daily Clinical Practice: An Italian Survey. pubmed/26454195

9 An Open Letter to the Food and Drug Administration Regarding the Use of Parker et al. http://www.ncbi.nlm.nih.gov/
Morcellation Procedures in Women Having Surgery for Presumed Uterine pubmed/26773577
Myomas.

10 Morcellation of undiagnosed uterine sarcoma: A critical review. Bogani et al Crit Rev Oncol Hematol http://www.ncbi.nlm.nih.gov/
J Obstet Gynaecol Res. pubmed/26672915
11 Differential diagnosis between uterine sarcoma and leiomyoma using preo- Cho et al. Magn. Reson. Imaging
perative clinical characteristics. http://www.ncbi.nlm.nih.gov/
pubmed/26695124
12 Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusi- Lin et al.
on weighted MRI in differentiation between uterine leiomyosarcoma/smooth http://www.ncbi.nlm.nih.gov/
muscle tumour of uncertain malignant potential and benign leiomyoma. pubmed/26383110

13 Gemcitabine-based chemotherapy in sarcomas: A systematic review of Ducoulombier et al. Crit Rev Oncol Hematol http://www.ncbi.nlm.nih.gov/
published trials. Expert Rev Anticancer Ther. pubmed/26555460

14 The role of adjuvant therapy in uterine leiomyosarcoma. Ducie et al. http://www.ncbi.nlm.nih.gov/
pubmed/26558647

International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 32